Terms: = Prostate cancer AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD
68644 results:
1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
[TBL] [Abstract] [Full Text] [Related]
2. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
[TBL] [Abstract] [Full Text] [Related]
3. Transcription Factors in prostate cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches.
Silva KCS; Tambwe N; Mahfouz DH; Wium M; Cacciatore S; Paccez JD; Zerbini LF
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674385
[TBL] [Abstract] [Full Text] [Related]
4. Treatment of Osteoporosis in Men on Androgen Deprivation Therapy in Japan.
Nishimoto H; Inui A; Mifune Y; Yamaura K; Bando Y; Okamura Y; Hara T; Terakawa T; Kuroda R
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674197
[No Abstract] [Full Text] [Related]
5. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
[TBL] [Abstract] [Full Text] [Related]
6. Synthesis and Validation of TRIFAPYs as a Family of Transfection Agents for Therapeutic Oligonucleotides.
Isanta B; Delgado A; Ciudad CJ; Busquets MA; Griera R; Llor N; Noé V
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672408
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer.
Yang L; Tang Y; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
Sci Rep; 2024 Apr; 14(1):9570. PubMed ID: 38671021
[TBL] [Abstract] [Full Text] [Related]
8. Parathyroid hormone related-protein (PTHrP) in tissues with poor prognosis in prostate cancer patients.
Zhao Y; Lu SM; Zhong B; Wang GC; Jia RP; Wang Q; Long JH
Medicine (Baltimore); 2024 Apr; 103(17):e37934. PubMed ID: 38669432
[TBL] [Abstract] [Full Text] [Related]
9. Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant prostate cancer.
Turnham DJ; Mullen MS; Bullock NP; Gilroy KL; Richards AE; Patel R; Quintela M; Meniel VS; Seaton G; Kynaston H; Clarkson RWE; Phesse TJ; Nelson PS; Haffner MC; Staffurth JN; Pearson HB
Cells; 2024 Apr; 13(8):. PubMed ID: 38667288
[TBL] [Abstract] [Full Text] [Related]
10. An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in prostate cancer Cells.
Champagne A; Chebra I; Jain P; Ringuette Goulet C; Lauzier A; Guyon A; Neveu B; Pouliot F
Biosensors (Basel); 2024 Apr; 14(4):. PubMed ID: 38667168
[TBL] [Abstract] [Full Text] [Related]
11. Breakthrough electroneutron multi-response miniature dosimetry/spectrometry in medical accelerator.
Sohrabi M; Malekitakbolagh M; Nedaei HA
Sci Rep; 2024 Apr; 14(1):9557. PubMed ID: 38664481
[TBL] [Abstract] [Full Text] [Related]
12. Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.
Jahnen M; Amiel T; Kirchoff F; Büchler JW; Herkommer K; Rothe K; Meissner VH; Gschwend JE; Lunger L
World J Urol; 2024 Apr; 42(1):260. PubMed ID: 38664275
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Correlates of prostate-Specific Membrane Antigen Expression and Response to
Raychaudhuri R; Mo G; Tuchayi AM; Graham L; Gulati R; Pritchard CC; Haffner MC; Yezefski T; Hawley JE; Cheng HH; Yu EY; Grivas P; Montgomery RB; Nelson PS; Chen DL; Hope T; Iravani A; Schweizer MT
JCO Precis Oncol; 2024 Apr; 8():e2300634. PubMed ID: 38662984
[TBL] [Abstract] [Full Text] [Related]
14. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
15. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
Ying Y; Wu Y; Zhang F; Tang Y; Yi J; Ma X; Li J; Chen D; Wang X; Liu X; Liu B; Luo J; Zheng X; Xie L
Mol Cancer; 2024 Apr; 23(1):79. PubMed ID: 38658974
[TBL] [Abstract] [Full Text] [Related]
16. Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery.
Mehring G; Steinbach C; Pose R; Knipper S; Koehler D; Werner S; Riethdorf S; von Amsberg G; Ambrosini F; Maurer T
World J Urol; 2024 Apr; 42(1):256. PubMed ID: 38656636
[TBL] [Abstract] [Full Text] [Related]
17. Infection risk reduction with povidone-iodine rectal disinfection prior to transrectal prostate biopsy: an updated systematic review and meta-analysis.
Tsuboi I; Matsukawa A; Parizi MK; Klemm J; Mancon S; Chiujdea S; Fazekas T; Laukhtina E; Kawada T; Katayama S; Iwata T; Bekku K; Wada K; Araki M; Shariat SF
World J Urol; 2024 Apr; 42(1):252. PubMed ID: 38652324
[TBL] [Abstract] [Full Text] [Related]
18. Developing a Novel Enzalutamide-Resistant prostate cancer Model via AR F877L Mutation in LNCaP Cells.
Wang R; Ma S; Xu N; Gan Y; Li P; Zhang J; Zhang Z; Gu Q; Xiang J
Curr Protoc; 2024 Apr; 4(4):e1033. PubMed ID: 38652202
[TBL] [Abstract] [Full Text] [Related]
19. [Antibacterial prophylaxis with fosfomycin at the time of the urethral catheter removal after radical prostatectomy (prospective randomized trial)].
Veliev E I; Sokolov E A; Metelev A Y; Aliev E N; Polyakova A S; Ivkin E V
Urologiia; 2024 Mar; (1):35-40. PubMed ID: 38650404
[TBL] [Abstract] [Full Text] [Related]
20. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
[TBL] [Abstract] [Full Text] [Related]
[Next]